window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 27, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

advanced therapies

  • Advanced Therapies,Clinical & Regulatory,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development

    Atsena receives EMA orphan designation for two inherited retinal disease gene therapies

    Atsena Therapeutics has received EMA orphan designation for two gene [...]

    July 24, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Delivery & Formulation,Research & Development

    EpilepsyGTx partners with ClearPoint Neuro to support Phase 1 gene therapy trial

    EpilepsyGTx has partnered with ClearPoint Neuro to support the targeted [...]

    July 14, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Australian Phase 1 trial begins for CAR-T therapy targeting solid tumours

    A Phase 1/1b clinical trial has begun in Australia to [...]

    July 10, 2026
  • Advanced Therapies,Drug Discovery & Development,Research & Development,Therapeutic Areas

    Atsena selects clinical candidate for Stargardt disease gene therapy

    ATSN-401, Atsena Therapeutics’ investigational gene therapy for Stargardt disease, has [...]

    July 10, 2026
  • Advanced Therapies,Digital & Data,Manufacturing & Supply Chain

    Autolomous and Cellular Origins integrate platforms for automated cell therapy manufacturing

    Autolomous and Cellular Origins have integrated their manufacturing platforms to [...]

    July 9, 2026
  • Advanced Therapies,Digital & Data,Manufacturing & Supply Chain,Research & Development

    Autolomous and Cellular Origins integrate platforms for cell therapy manufacturing

    Autolomous and Cellular Origins have integrated their platforms to create [...]

    July 8, 2026
  • Advanced Therapies,Manufacturing & Supply Chain,Medical devices,Research & Development

    Bio-Rad launches Vericheck ddPCR kits for cell and gene therapy quality control

    Bio-Rad Laboratories has launched a portfolio of Vericheck ddPCR kits [...]

    July 8, 2026
  • Advanced Therapies,Genomics and sequencing,Research & Development,Therapeutic Areas

    Genespire reports preclinical gene therapy data for methylmalonic acidemia

    Genespire and researchers at the San Raffaele Telethon Institute for [...]

    July 8, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Meteor Biotech joins South Korea consortium to advance brain organoid commercialisation platform

    Meteor Biotech has joined a South Korean government-backed consortium aimed [...]

    June 23, 2026
  • Advanced Therapies

    Houdini Bio develops DNA design platform targeting gene therapy silencing

    Houdini Bio has launched a machine learning-guided DNA sequence design [...]

    June 19, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Natus expands AI-powered EEG analysis across Europe
    Categories: Central Nervous System, Digital & Data, Medical devices
  • Enterome data link CD8 T-cell expansion to progression-free survival in lymphoma
    Categories: Advanced Therapies, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Telix starts Phase 3 trial of radiopharmaceutical therapy for renal cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top